User profiles for David D. Bushart

David Bushart

Ohio State University College of Medicine
Verified email at osumc.edu
Cited by 413

[PDF][PDF] Nicotinamide pathway-dependent Sirt1 activation restores calcium homeostasis to achieve neuroprotection in spinocerebellar ataxia type 7

CA Stoyas, DD Bushart, PM Switonski, JM Ward… - Neuron, 2020 - cell.com
Sirtuin 1 (Sirt1) is a NAD + -dependent deacetylase capable of countering age-related
neurodegeneration, but the basis of Sirt1 neuroprotection remains elusive. Spinocerebellar ataxia …

Ion channel dysfunction in cerebellar ataxia

DD Bushart, VG Shakkottai - Neuroscience letters, 2019 - Elsevier
Cerebellar ataxias constitute a heterogeneous group of disorders that result in impaired
speech, uncoordinated limb movements, and impaired balance, often ultimately resulting in …

Targeting potassium channels to treat cerebellar ataxia

DD Bushart, R Chopra, V Singh… - Annals of clinical …, 2018 - Wiley Online Library
Objective Purkinje neuron dysfunction is associated with cerebellar ataxia. In a mouse model
of spinocerebellar ataxia type 1 ( SCA 1), reduced potassium channel function contributes …

Altered Capicua expression drives regional Purkinje neuron vulnerability through ion channel gene dysregulation in spinocerebellar ataxia type 1

…, DD Bushart, JP Cooper, D Yellajoshyula… - Human molecular …, 2020 - academic.oup.com
Selective neuronal vulnerability in neurodegenerative disease is poorly understood. Using
the ATXN1[82Q] model of spinocerebellar ataxia type 1 (SCA1), we explored the hypothesis …

[HTML][HTML] Antisense oligonucleotide therapy rescues aggresome formation in a novel spinocerebellar ataxia type 3 human embryonic stem cell line

LR Moore, L Keller, DD Bushart, RG Delatorre, D Li… - Stem cell …, 2019 - Elsevier
Spinocerebellar ataxia type 3 (SCA3) is a fatal, late-onset neurodegenerative disorder
characterized by selective neuropathology in the brainstem, cerebellum, spinal cord, and …

A Chlorzoxazone‐Baclofen Combination Improves Cerebellar Impairment in Spinocerebellar Ataxia Type 1

DD Bushart, H Huang, LJ Man, LM Morrison… - Movement …, 2021 - Wiley Online Library
Background A combination of central muscle relaxants, chlorzoxazone and baclofen (chlorzoxazone‐baclofen),
has been proposed for treatment of cerebellar symptoms in human …

Antisense Oligonucleotide Therapy Targeted Against ATXN3 Improves Potassium Channel–Mediated Purkinje Neuron Dysfunction in Spinocerebellar Ataxia Type 3

DD Bushart, AJ Zalon, H Zhang, LM Morrison, Y Guan… - The Cerebellum, 2021 - Springer
Spinocerebellar ataxia type 3 (SCA3) is the second-most common CAG repeat disease,
caused by a glutamine-encoding expansion in the ATXN3 protein. SCA3 is characterized by …

[HTML][HTML] Dendritic potassium channel dysfunction may contribute to dendrite degeneration in spinocerebellar ataxia type 1

R Chopra, DD Bushart, VG Shakkottai - PLoS One, 2018 - journals.plos.org
Purkinje neuron dendritic degeneration precedes cell loss in cerebellar ataxia, but the basis
for dendritic vulnerability in ataxia remains poorly understood. Recent work has suggested …

[HTML][HTML] Precision medicine in spinocerebellar ataxias: treatment based on common mechanisms of disease

DD Bushart, GG Murphy… - Annals of Translational …, 2016 - ncbi.nlm.nih.gov
Spinocerebellar ataxias (SCAs) are a heterogeneous group of dominantly inherited
neurodegenerative disorders affecting the cerebellum and its associated pathways. There are no …

[HTML][HTML] Synthetic high-density lipoprotein nanoparticles for the treatment of Niemann–Pick diseases

…, R Ming, EE Morin, HS McLoughlin, DD Bushart… - BMC medicine, 2019 - Springer
Background Niemann–Pick disease type C is a fatal and progressive neurodegenerative
disorder characterized by the accumulation of unesterified cholesterol in late endosomes and …